KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Current Leases (2019 - 2025)

Opko Health (OPK) has disclosed Current Leases for 7 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Leases fell 86.64% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, down 86.64%, and an annual FY2025 reading of $1.7 million, down 86.64% over the prior year.
  • Current Leases was $1.7 million for Q4 2025 at Opko Health, up from $1.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $12.6 million in Q4 2024 and bottomed at $1.5 million in Q3 2025.
  • Average Current Leases over 5 years is $5.3 million, with a median of $2.8 million recorded in 2022.
  • Peak annual rise in Current Leases hit 455.06% in 2025, while the deepest fall reached 86.64% in 2025.
  • Year by year, Current Leases stood at $11.6 million in 2021, then tumbled by 75.83% to $2.8 million in 2022, then increased by 0.64% to $2.8 million in 2023, then skyrocketed by 347.44% to $12.6 million in 2024, then crashed by 86.64% to $1.7 million in 2025.
  • Business Quant data shows Current Leases for OPK at $1.7 million in Q4 2025, $1.5 million in Q3 2025, and $9.9 million in Q2 2025.